Integrative Healthcare Goes to Washington with the Congressional Integrative Health and Wellness Caucus

Capitol Hill Legislators and Staffers Get a Hands-On Introduction to Integrative Medicine WASHINGTON DC – On March 6, 2019, the second annual Congressional Integrative Health and Wellness Caucus, co-led by Rep. Judy Chu (D-CA), and Rep. Jackie Walorski (R-IN), was held for an audience of 50 Democratic and Republican HouseRead …

Read moreIntegrative Healthcare Goes to Washington with the Congressional Integrative Health and Wellness Caucus

FDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products

Legal Cannabis

 Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to advance agency’s continued evaluation of potential regulatory pathways for cannabis-containing and cannabis-derived products In recent years, we’ve seen a growing interest in the development of therapies and other FDA-regulated consumer products derived from cannabis (Cannabis sativa L.) and itsRead …

Read moreFDA Commissioner Scott Gottlieb, M.D. on Public Hearing for Cannabis-containing and Cannabis-derived Products

Ned Sharpless, MD, from National Cancer Institute (NCI), is Acting Commissioner of the Food and Drug Administration

The White House recently announced its intention to appoint Dr. Ned Sharpless, current director of the National Cancer Institute (NCI), as acting commissioner of the Food and Drug Administration (FDA). Dr. Doug Lowy, current deputy director at NCI, will take over as acting director. “Dr. Sharpless has demonstrated extraordinary leadershipRead …

Read moreNed Sharpless, MD, from National Cancer Institute (NCI), is Acting Commissioner of the Food and Drug Administration

Exclusive Interview with Dr. Paul Anderson: The FDA and the Fate of Compounded Medicines

compounded medicine

The following is an excerpt of interview with Paul Anderson, ND on the FDA’s recent stance on compounded medicine as published in the Journal of Restorative Medicine, Volume 8, Number 1, 4 January 2019, pp. 1-5(5). The Journal of Restorative Medicine (JRM) recently interviewed Paul Anderson, ND, who is testifyingRead …

Read moreExclusive Interview with Dr. Paul Anderson: The FDA and the Fate of Compounded Medicines

Academy of Integrative Pain Management Makes Painful Decision to Cease Operations

Lenexa, KS, January 29, 2019 – After thirty years as the nation’s leading voice for integrative pain management, the Academy of Integrative Pain Management (AIPM) will cease operations and solicit members’ permission to dissolve as an organization in the coming weeks. AIPM’s Board of Directors voted unanimously on January 26Read …

Read moreAcademy of Integrative Pain Management Makes Painful Decision to Cease Operations

Congressional Reps. Judy Chu and Jackie Walorski to Lead Bipartisan Congressional Integrative Health and Wellness Caucus

WASHINGTON, D.C., January 29, 2019– The bipartisan Congressional Integrative Health and Wellness Caucus has been registered with two new co-chairs at the helm for the 116th Congress. Representative Judy Chu (CA-21st) will serve as the Democratic leader with Representative Jackie Walorski (IN-2nd) as the Republican leader, replacing former Caucus co-chairsRead …

Read moreCongressional Reps. Judy Chu and Jackie Walorski to Lead Bipartisan Congressional Integrative Health and Wellness Caucus

ACT NOW! IHPC Call to Comment on HHS Pain Management Best Practices Inter-Agency Task Force

Want your voice heard about integrative pain management? The Pain Management Best Practices Interagency Task Force issued its draft report in late Dec. 2018. The comment period is open for the next 90 days, until March 28, 2019. The Pain Management Best Practices Inter-Agency Task Force (Task Force), in aRead …

Read moreACT NOW! IHPC Call to Comment on HHS Pain Management Best Practices Inter-Agency Task Force

Effectiveness of Prescription CBD for Epilepsy May Wane in a Quarter of Patients

Prescription CBD for Epilepsy

Approximately 25 percent of drug-resistant epilepsy patients taking cannabidiol (CBD) developed a tolerance to the treatment, researchers said at the American Epilepsy Society annual meeting taking place Nov.30 – Dec. 4, 2018. The findings suggest that that the effectiveness of the CBD drug might wane in the long term forRead …

Read moreEffectiveness of Prescription CBD for Epilepsy May Wane in a Quarter of Patients

Two Myth Busting Studies: Health Risks of Sitting & the Benefits of Short-Burst High Intensity Exercise

health risks of sitting

In recent years, every major news outlet, and even medical journals, reported that the health risks of sitting at a desk for 8 hours were equal to smoking. It was a bold statement. The news spread faster than office gossip, prompting office workers to switch to adjustable desks that allowRead …

Read moreTwo Myth Busting Studies: Health Risks of Sitting & the Benefits of Short-Burst High Intensity Exercise